Anagnostics | GenomeWeb

Anagnostics

Anagnostics aims to include the marker in a new version of its Hybcell Inflammation integrated sepsis monitoring test.

The researchers are also developing the method in tandem with a more extensive pathogen profiling diagnostic platform from Swedish startup Q-linea.

NEW YORK (GenomeWeb) – Austrian molecular diagnostics firm Anagnostics recently launched a new assay designed to detect sepsis-associated bacteria and fungi using a single array.

Anagnostics is planning to expand its sales and marketing activities in the EU as well as the US as it narrows its focus to its nascent integrated sepsis diagnostics business.

Austrian molecular diagnostics firm Anagnostics said this week that it has received CE-IVD approval for two tests based on its Hybcell cylindrical microarray platform.

Austrian molecular diagnostics firm Anagnostics said this week that it is now using Scienion's SciFlexarrayer to produce its cylindrical Hybcell arrays.

NEW YORK (GenomeWeb News) – Scienion and Anagnostics Bioanalysis today said that Anagnostics is using Scienion's SciFlexArrayer in the production of Anagnostics' new products focused on integrating sepsis testing.

Austrian array company Anagnostics recently achieved a CE-IVD mark for a test that could help clinicians guide treatment for patients with sepsis. Separately, the firm announced a new distribution partnership in Belgium, further expanding its presence in Europe.

Nanosphere has appointed Roy Davis to its board of directors.

This story has been updated to include comments from company executives.
Austrian array company Anagnostics Bioanalysis recently announced a deal with Molzym to develop and launch a test for sepsis.

Pages

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.